NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial

NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial

ObjectivesThe effect and safety of Nasafytol®, a food supplement combining curcumin, quercetin, and Vitamin D, on hospitalized COVID-19-positive patients as support to standard of care were to be assessed.MethodsThis exploratory, open-label, randomized, controlled trial was carried out among hospita...

Full description

Bibliographic Details
Main Authors: Jean Gérain, Melanie Uebelhoer, Bérénice Costes, Julie Herman, Sandra Pietri, Anne-Françoise Donneau, Justine Monseur, Yves Henrotin
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Nutrition
Subjects:
COVID-19
SARS–CoV-2
coronavirus
food supplement
curcumine
quercetine
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1137407/full

Internet

https://www.frontiersin.org/articles/10.3389/fnut.2023.1137407/full

Similar Items